We are live on ! Find out more
TCM

Tang Capital Management Portfolio holdings

AUM $1.97B
1-Year Est. Return 125.1%
This Fund
S&P 500
This Quarter Est. Return
+65.41%
1 Year Est. Return
+125.1%
3 Year Est. Return
+474.48%
5 Year Est. Return
+595.08%
10 Year Est. Return
+2,831.44%
AUM
$330M
AUM Growth
+$142M
Cap. Flow
-$6.37M
Cap. Flow %
-1.93%
Top 10 Hldgs %
100%
Holding
9
New
1
Increased
2
Reduced
–
Closed
3

Top Buys

Rank Stock Value
1
BRLI
BIO-REFERENCE LABS INC-NEW-
BRLI
+$32.3M
2
LJPC
La Jolla Pharmaceutical Company
LJPC
+$10.7M
3
HRTX icon
Heron Therapeutics
HRTX
+$5.1M

Top Sells

Rank Stock Value
1
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$11.4M
2
ACHV icon
Achieve Life Sciences
ACHV
+$1.35M
3
PHIO icon
Phio Pharmaceuticals
PHIO
+$1.13M

Sector Composition

Rank Sector Weight
1 Healthcare 76.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HRTX icon
1
Heron Therapeutics
HRTX
$86.3M
$162M 49.08%
5,190,837
+271,212
+6% +$5.1M
LJPC
2
DELISTED
La Jolla Pharmaceutical Company
LJPC
$65.3M 19.82%
2,664,970
+520,583
+24% +$10.7M
BRLI
3
DELISTED
BIO-REFERENCE LABS INC-NEW-
BRLI
$37.1M 11.26%
+900,000
New +$32.3M
BMRN icon
4
BioMarin Pharmaceuticals
BMRN
$11.5B
$24.9M 7.57%
182,300
– –
ACHV icon
5
Achieve Life Sciences
ACHV
$626M
– –
-286
Closed -$1.35M
PHIO icon
6
Phio Pharmaceuticals
PHIO
$12.1M
– –
-3
Closed -$1.13M
MRTX
7
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
– –
-388,543
Closed -$11.4M

Similar funds

HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
SGAM
Smith Group Asset Management Dallas, Texas $1.96B AUM 43.61% 1-Year Est. Return
CCA
Checchi Capital Advisers Beverly Hills, California $1.98B AUM 19.17% 1-Year Est. Return
FWTB
First Western Trust Bank Denver, Colorado $1.98B AUM 1.62% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
RMCM
Reynders McVeigh Capital Management Boston, Massachusetts $1.98B AUM 23.37% 1-Year Est. Return
FC
Finepoint Capital Boston, Massachusetts $1.95B AUM 45.61% 1-Year Est. Return
SC
Syon Capital San Francisco, California $1.99B AUM 22.67% 1-Year Est. Return

Tang Capital Management's Q2 2015 Portfolio in Review

As of Q2 2015, Tang Capital Management held 9 positions worth $330M, up 75% from $188M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Tang Capital Management's Q2 2015 filing shows 1 new, 2 increased and 3 closed positions. Its largest new stake was BIO-REFERENCE LABS INC-NEW-: 900,000 shares worth $37.1M. The largest sale was Mirati Therapeutics, Inc. Common Stock, an estimated $11.4M.

By sector, the portfolio is most concentrated in Healthcare at 76% of assets, down from 78% a quarter earlier.

  • Tang Capital Management's largest Q2 2015 buy was BIO-REFERENCE LABS INC-NEW-: 900,000 shares worth $37.1M.
  • Tang Capital Management added most to La Jolla Pharmaceutical Company in Q2 2015, an estimated $10.7M increase.
  • Tang Capital Management fully exited Mirati Therapeutics, Inc. Common Stock in Q2 2015, selling an estimated $11.4M.
  • Tang Capital Management's ten largest holdings make up 100% of its $330M portfolio in Q2 2015.
  • Tang Capital Management opened 1 new position and closed 3 in Q2 2015.
  • Tang Capital Management's portfolio value rose 75% quarter-over-quarter to $330M.

Based on Tang Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.